Project Consultation
We discuss your specific glycosylase target, substrate of interest, and experimental goals (e.g., screening, kinetics, variant analysis).
Base Excision Repair (BER) glycosylases are specialized enzymes that serve as the essential initiators and editors of genome integrity. CD BioSciences provides comprehensive, quantitative BER Glycosylase Activity Assay services. Utilizing state-of-the-art biochemical platforms, we deliver precise kinetic and functional profiling of key enzymes like TDG, SMUG1, and MBD4, empowering your research into genomic stability, epigenetic reprogramming, and their roles in disease pathogenesis and aging.
BER glycosylases are the initial and crucial enzymes in the Base Excision Repair pathway. They recognize chemically altered DNA bases, cleave the N-glycosidic bond to release the damaged base, and create an abasic site. Their primary role is to correct common DNA damage like oxidative lesions, deaminated bases, and alkylation damage. Beyond repair, a subset, notably TDG and SMUG1, participates in active DNA demethylation. TDG excises oxidized 5-methylcytosine derivatives (5fC/5caC) generated by TET enzymes, while SMUG1 removes 5hmU. This excision initiates BER-mediated restoration of unmethylated cytosine, linking genome maintenance to epigenetic regulation. Dysregulation of these enzymes is associated with cancer, neurological disorders, and aging, highlighting their biological significance.

Fig.1 Schematic Diagram of the Base Excision Repair (BER) Process. (Hindi N N, et al., 2021)
Quantifying BER glycosylase activity is vital for studying cellular responses to genotoxic stress and epigenetic dynamics. In DNA repair research, measuring enzymes like OGG1 or UNG provides a direct functional readout of a cell's ability to handle endogenous damage, serving as a biomarker for aging, neurodegeneration, and cancer risk. In epigenetics, assaying TDG activity is essential for investigating the final step of TET-driven active demethylation, as its efficiency directly impacts epigenetic reprogramming in development and differentiation. Moreover, since glycosylase activity often alters in tumors, functional assessment can reveal novel disease mechanisms.
CD BioSciences's provides quantitative assay services to precisely characterize the function of key enzymes like TDG and SMUG1 in DNA damage repair and active demethylation. Utilizing a multi-platform approach including fluorescence, gel electrophoresis, and mass spectrometry, we perform kinetic analysis and inhibitor screening on both purified enzymes and complex biological samples.
Our project execution follows a streamlined, collaborative five-phase workflow designed for transparency, efficiency, and scientific rigor. This process ensures that your project is meticulously planned, expertly executed, and delivers actionable data on time.
Project Consultation
We discuss your specific glycosylase target, substrate of interest, and experimental goals (e.g., screening, kinetics, variant analysis).
Assay Design & Substrate Preparation
We design the optimal assay format and prepare the required lesion-containing oligonucleotide substrates, either from our stock or through custom synthesis.
Assay Optimization & Validation
The reaction conditions (buffer, pH, salt, time, enzyme concentration) are optimized for your specific enzyme-substrate pair to ensure linearity and robustness.
Sample Testing & Data Acquisition
Your provided samples (purified enzyme or cell extracts) are tested in replicate, alongside positive and negative controls, on the selected platform (fluorescent plate reader, gel scanner, or LC-MS/MS).
Data Analysis & Reporting
Data is analyzed to calculate activity rates, kinetic parameters, or inhibition values. You receive a detailed report with all experimental procedures, raw and analyzed data, and a clear summary of conclusions.

Mechanistic Studies of Active Demethylation
Precisely measure TDG excision kinetics on 5caC/5fC substrates to define the efficiency and sequence-context dependence of the final step in TET-mediated demethylation.
DNA Repair Capacity Biomarker Analysis
Profile the activity of OGG1, UNG, or other glycosylases in cell or tissue lysates to assess an individual's or a disease model's base excision repair capacity, relevant for aging, neurodegeneration, and cancer susceptibility studies.


Inhibitor Discovery for Novel Therapeutics
Conduct high-throughput screening campaigns to identify small molecules that selectively inhibit TDG (for potential use in oncology) or activate OGG1 (for chemoprevention), followed by detailed mechanistic characterization.
Characterization of Enzyme Variants
Characterize the activity of wild-type versus mutant or polymorphic variants of BER glycosylases (e.g., cancer-associated MUTYH variants) to determine the functional impact of genetic changes.

For each project, you will receive a complete data package designed for immediate analysis and reporting, including:

Q1: What substrates do you recommend for assaying TDG activity in the context of active demethylation?
Q2: Can you analyze BER glycosylase activity from crude cell lysates or tissue samples?
Q3: What is the minimum amount of purified enzyme required for a kinetic study?
Q4: How do you distinguish between monofunctional (only glycosylase) and bifunctional (glycosylase/AP lyase) glycosylase activity?
Q5: What deliverables do you provide for an inhibitor screening project?
BER glycosylases are critical sentinels of genetic and epigenetic integrity. CD BioSciences provides the expert services and sophisticated platforms needed to precisely dissect their activity. Our customized, quantitative assays deliver the reliable data required to advance your research in DNA repair, active DNA demethylation, and their profound implications in health and disease. Contact us to discuss how we can tailor a BER glycosylase activity study to your specific research needs.
Reference
1. Hindi N N, Elsakrmy N, Ramotar D. The base excision repair process: comparison between higher and lower eukaryotes[J]. Cellular and Molecular Life Sciences, 2021, 78(24): 7943-7965.
USA
Quick Links
Easy access to products and services you need from our library via powerful searching tools
Privacy Policy | Cookie Policy
Copyright © 2026 CD BioSciences. All Rights Reserved.